Kymera Therapeutics Q3 EPS $(1.32) Misses $(1.27) Estimate
Benzinga Newsdesk 2 days ago
NewsEarningsEarnings Misses
Kymera Therapeutics (NASDAQ:KYMR) reported quarterly losses of $(1.32) per share which missed the analyst consensus estimate of $(1.27) by 3.94 percent. This is a 40.43 percent decrease over losses of $(0.94) per share
Kymera Therapeutics (NASDAQ:KYMR) reported quarterly losses of $(1.32) per share which missed the analyst consensus estimate of $(1.27) by 3.94 percent. This is a 40.43 percent decrease over losses of $(0.94) per share from the same period last year.